培米替尼在哪买的到？

Pemetinib is used for cholangiocarcinoma that has metastasized (spread to other parts of the body) or is locally advanced and cannot be treated by surgery, as well as for the treatment of adult cholangiocarcinoma patients with FGFR2 gene fusion or other changes in the FGFR2 gene structure; pemetinib is the world's first targeted therapy for cholangiocarcinoma. Cholangiocarcinoma is a rare cancer that develops in the long, thin bile ducts that carry digestive juices from the liver to the gallbladder and small intestine. At the time of diagnosis, most patients with cholangiocarcinoma have an advanced stage, meaning they cannot undergo surgical treatment. For these patients, chemotherapy combinations have become the standard initial treatment. Fibrocyte growth factor receptor 2 (FGFR2) fusions are found in the tumors of approximately 9% to 14% of patients with cholangiocarcinoma. The approval applies to patients with locally advanced or metastatic cholangiocarcinoma whose tumors harbor FGFR2 gene fusions or other rearrangements. Pemetinib tablets prevent the growth and spread of tumors by inhibiting FGFR2 in tumor cells.

Where can I buy pemetinib?

Pemetinib has not yet been officially launched in China. Therefore, it is not on display and sold in China. Patients in need can purchase the version listed abroad. The price of pemetinib varies due to exchange rate fluctuations. Please consult the medical companion for specific prices! 

If you want to buy medicines listed abroad, but it is inconvenient to go abroad, the most reliable way is to buy them through regular domestic overseas medical service institutions, which will sign a guarantee contract for you. The medicines and money will not be handled by them, and will be mailed to the patient by direct mail, guaranteeing 100% authenticity!

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: